Characterization of a primate model of asthma using anti-allergy/ anti-asthma agents

Inflammation Research

Volumn 45, Issue 5, 1996, Pages 239-245

  Turner, C R ^a   Andresen, C J ^a   Smith, W B ^a   Watson, J W ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Airway hyperresponsiveness; Anti histamine; Monkey; Steroid; agonist

Indexed keywords

ANTIALLERGIC AGENT; ANTIASTHMATIC AGENT; CETIRIZINE; DEXAMETHASONE; MEPYRAMINE; METHACHOLINE; SALBUTAMOL; SALMETEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; ATOPY; BRONCHOSPASM; CONTROLLED STUDY; EOSINOPHIL; INHALATIONAL DRUG ADMINISTRATION; LEUKOCYTE; MALE; MONKEY; NONHUMAN; PRIMATE; STATISTICAL ANALYSIS; SUBCUTANEOUS DRUG ADMINISTRATION;

ALBUTEROL; ANIMALS; ANTI-ALLERGIC AGENTS; ANTI-INFLAMMATORY AGENTS; ANTIGENS; ASTHMA; BRONCHOCONSTRICTION; BRONCHOCONSTRICTOR AGENTS; BRONCHODILATOR AGENTS; CETIRIZINE; DEXAMETHASONE; DISEASE MODELS, ANIMAL; LEUKOCYTES; MACACA FASCICULARIS; MALE; METHACHOLINE CHLORIDE; PYRILAMINE;

EID: 0030001459     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02259610     Document Type: Article

References (34)

1. Patterson R. Animal models demonstrating respiratory responses to inhalant antigens. Yale J Biol Med 1968;40:495-500.
2. Kosch PC, Gillespie JR, Berry JD. Respiratory mechanics in normal bonnet and rhesus monkeys. J Appl Physiol 1979;46:166-75.
3. Krell RD. Airway hyperreactivity to pharmacologic agents in rhesus monkeys cutaneously hypersensitive to ascaris antigen. Life Sci 1976;19:1777-82.
4. Gundel RH, Gerritsen ME, Gleich GJ, Wegner CD. Repeated antigen inhalation results in a prolonged airway eosinophilia and airway hyperresponsiveness in primates. J Appl Physiol 1990;68:779-86.
5. Gundel RH, Wegner CD, Letts LG. Antigen-induced acute and late-phase responses in primates. Am Rev Respir Dis 1992; 146:369-73.
6. 4 Receptor Antagonism Reduces Airway Hyperresponsiveness in Monkeys. Pulmon Pharmacol 1994;7: 49-58.
7. Turner CR, Andresen CJ, Smith WB, Watson JW. Effect of rolipram on responses to acute and chronic antigen exposure in monkeys. Am J Respir Crit Care Med 1994;149:1153-9.
8. Gundel RH, Torcellinini CA, Clarke CC, Desai SN, Lazer ES, Wegner CD. The effects of a 5-lipoxygenase inhibitor on antigen-induced mediator release, late phase bronchoconstriction and cell infiltrates in primates. Adv in Prostagland Thromb Leukotr Res 1991;88:1407-11.
9. Gundel RH, Letts LG, Wegner CD. The role of platelet activating factor in airway inflammation, airway hyperresponsiveness and pulmonary function in monkeys. Ann NY Acad Sci 1991;629:205-16.
10. Wegner CD, Gundel RH, Reilly P, Haynes N, Letts LG, Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 1990;247:456-9.
11. 1 receptor antagonists. Clin Pharm 1989;8:331-44.
12. Redier H, Chenez P, DeVos C, Rifai N, Clauzel AM, Michel FB, et al. Inhibitory effect of cetirizine on the bronchial eosinophil recruitment induced by allergen inhalation challenge in allergic patients with asthma. J Allergy Clin Immunol 1992;90:215-24.
13. 1 antihistamine, on the early and late allergic reactions in a bronchial provocation test with allergen. J Allergy Clin Immunol 1993;91:1189-97.
14. 2 adrenoreceptor agonist: comparison with salbutamol in adult asthmatic patients. Thorax 1988;43:674-8.
15. Sanjar S, McCabe PJ, Reynolds LH, Johnson M. Salmeterol inhibits antigen-induced eosinophil accumulation in the guinea pig lung. Fund Clin Pharmacol 1991;5:402.
16. Djukanovic R, Wilson JW, Britten KM, Wilson SJ, Walls AF, Roche WR, et al. Effect of inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis 1992;145:669-74.
17. Wegner CD, Jackson AC, Berry JD, Gillespie JR. Dynamic respiratory mechanics in monkeys measured by forced oscillations. Respir Physiol 1984;55:47-61.
18. 4- and antigen-induced bronchoconstriction in Cynomolgus monkeys. Pulmon Pharmacol 1992;5:153-7.
19. Rafferty P, Ghosh SK, DeVos C, Patel KR. Effect of oral and inhaled cetirizinein allergen induced bronchoconstriction. Clin Exp Allergy 1993;23:528-31.
20. Pelikan Z. Effects of cetirizine (CZ) on the immediate (INR) and late nasal response (LNR) and on the eosinophils in the nasal secretions (NS). J Allergy Clin Immunl 1993;91:193.
21. Twentyman OP, Finnerty JP, Harris A, Palmer J, Holgate ST. Protection against allergen-induced asthma by salmeterol. 1990;336:1338-42.
22. Gundel RH, Kinkade P, Torcellini CA, Clarke CC, Watrous J, Desai S, et al. Antigen-induced mediator release in primates. Am Rev Respir Dis 1991;144:76-82.
23. Pepys J, Davies RJ, Breslin BX, Hendricks DJ. The effects of inhaled beclomethasone dipropionate (Becotide) and sodium cromoglycate on asthma reactions to provocation tests. Clin Allergy 1974;4:13-24.
24. Chung KF. Pharmacology of airway inflammation in asthma. Lung 1990;Suppl: 132-41.
25. Rieder H, Chanez P, De Vos C, et al. Inhibitory effect of cetirizine on the bronchial eosinophil recruitment induced by allergen inhalation challenge in allergic patients with asthma. J Allergy Clin Immunol 1992;90:215-24.
26. 1 effects of second generation antihistamines. Ann Allergy 1992; 68:190-6.
27. Morley J, Sanjar S, Newth C. Viewpoint: untoward effects of beta-adrenoreceptor agonists in asthma. Eur Resp J 1990;3: 228-33.
28. 2-adrenoceptor agonists: a new perspective in the treatment of asthma. Eur Resp J 1991;4:218-26.
29. Laitinen LA, Laitinen A, Haahtela T. Treatment of eosinophilic airway inflammation with inhaled corticosteroid, budesonide, in newly diagnosed asthmatic subjects. Eur Respir J 1991;4:342-7.
30. 1 and bronchial responsiveness in patients with asthma. Eur Respir J 1992;5: 32-9.
31. 2-agonist formoterol. Am Rev Respir Dis 1991;143:998-1001.
32. 1-receptor anti-histamines in the airways and skin of subjects with asthma. J Allergy Clin Immunol 1993;91:1005-14.
33. Spencer CM, Faulds D, Peters DH. Cetirizine. A Reappraisal of its pharmacological properties and therapeutic use in selected allergic disorders. Drugs 1993;46:1055-80.
34. Baroody FM, Cruz AA, Lichtenstein LM, Kagey-Sobotka A, Proud D, Naclerio RM. Intranasal beclomethasone inhibits antigen-induced nasal hyperresponsiveness to histamine. J Allergy Clin immunol 1992;90:373-6.